Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
3.43 USD | -1.72% | -6.28% | +1.48% |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | 329K | Capitalization | 131M |
---|---|---|---|---|---|
Net income 2024 * | -86M | Net income 2025 * | -105M | EV / Sales 2024 * | - |
Net cash position 2024 * | 113M | Net cash position 2025 * | 241M | EV / Sales 2025 * | -333 x |
P/E ratio 2024 * |
-1.82
x | P/E ratio 2025 * |
-1.81
x | Employees | 65 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 90.79% |
Latest transcript on Vigil Neuroscience, Inc.
1 day | -0.72% | ||
1 week | -6.28% | ||
Current month | +31.42% | ||
1 month | +20.77% | ||
3 months | +13.58% | ||
6 months | +4.89% | ||
Current year | +1.48% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 55 | 20-06-30 | |
Director of Finance/CFO | 50 | 20-06-30 | |
Kelly Neelon
CTO | Chief Tech/Sci/R&D Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 55 | 20-06-30 | |
Mary Thistle
BRD | Director/Board Member | 64 | 22-04-17 |
Cheryl Blanchard
BRD | Director/Board Member | 59 | 20-10-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.00% | 34 M€ | +4.54% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-21 | 3.43 | -1.72% | 13 718 |
24-05-20 | 3.49 | -0.85% | 62,277 |
24-05-17 | 3.52 | -0.56% | 49,336 |
24-05-16 | 3.54 | +1.58% | 32,182 |
24-05-15 | 3.485 | -4.78% | 52,802 |
Delayed Quote Nasdaq, May 21, 2024 at 01:04 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+1.48% | 131M | |
+42.10% | 54.04B | |
+43.57% | 41.96B | |
-1.20% | 41.92B | |
-7.59% | 28.35B | |
+12.21% | 26.35B | |
-22.56% | 19B | |
+7.81% | 13B | |
+28.86% | 12.28B | |
+25.16% | 12.19B |
- Stock Market
- Equities
- VIGL Stock